Jang Hyun Han

This inventor holds 19 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Hepatitis C Research. Top assignees: Chiron Corporation, Arrowhead Research Corporation, Novartis Vaccines & Diagnostics, Gmbh. Active years: 1994-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jang Hyun Han. Retrieved from https://idiyas.com/inventor/jang-hyun-han

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 5)

% Patents Active = 73.7

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 292(Granted Patents)

Company Filing History:

Arrowhead Research Corporation

patents

2 out of 245

Novartis Vaccines & Diagnostics, Gmbh

patents

4. 2 out of 10

Relia Diagnostic Systems, LLC

patents

5. 2 out of 4

The Director General of the National Institute of Health of Japan

where one patent can have more than one assignee

Years Active: 1994-2022

Loading Chart...

Areas of Expertise:

Hepatitis C

RNA Molecules

Viral Infection

Glycated Hemoglobin

HCV Proteins

Polynucleotides

Diagnostics

HCV NS3 Protein

Tissue Culture

Viral Treatment

HCV Fragments

Polypeptides

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11518788 - Methods and compositions for treating and preventing viral infection (2022-12-06),

2. 9459262 - Systems and methods for determining the percentage of glycated hemoglobin (2016-10-04),

3. 9139833 - Modified small interfering RNA molecules and methods of use (2015-09-22),

4. 9084808 - Modified small interfering RNA molecules and methods of use (2015-07-21),

5. 8765704 - Modified small interfering RNA molecules and methods of use (2014-07-01),

6. 8703494 - Systems and methods for determining the percentage of glycated hemoglobin (2014-04-22),

7. 8481050 - Tissue culture system for production of hepatitis C virus (2013-07-09),

8. 8138161 - Modified small interfering RNA molecules and methods of use (2012-03-20),

9. 7033805 - HCV NS3 protein fragments having helicase activity and improved solubility (2006-04-25),

10. 7018984 - Methods and compositions for controlling translation of HCV proteins (2006-03-28),

11. 6472180 - HCV NS3 protein fragments having helicase activity and improved solubility (2002-10-29),

12. 6194140 - HCV NS3 protein fragments having helicase activity and improved solubility (2001-02-27),

13. 6057093 - Methods and compositions for controlling translation of HCV proteins (2000-05-02),

14. 5989905 - HCV NS3 protein fragments having helicase activity and improved (1999-11-23),

15. 5922857 - Methods and compositions for controlling translation of HCV proteins (1999-07-13),

Title: The Innovative Mind of Jang Hyun Han

Introduction: Jang Hyun Han is a remarkable inventor based in Lafayette, CA, who has made significant contributions to the field of medical science. With a total of 19 patents to his name, his innovative work focuses on developing solutions for treating viral infections and analyzing medical samples.

Latest Patents: Among his latest patents is a groundbreaking method for treating and preventing viral infections. This patent discloses recombinant polypeptides that combine an immunoglobulin Fc fragment with at least one viral receptor or its fragment. Additionally, this innovation encompasses RNA molecules, therapeutic compositions, and expression systems that utilize these recombinant polypeptides, alongside methods aimed at preventing or treating viral infections in individuals.

Another notable patent of Jang Hyun Han addresses the quantitative analysis of glycated hemoglobin. This patent details systems and methods designed to assess a blood sample to determine the percentage of glycated hemoglobin accurately. These methods can be implemented in point-of-care devices and various in vitro diagnostic tools, making them highly applicable in medical diagnostics.

Career Highlights: Jang Hyun Han has worked at prestigious institutions, including Chiron Corporation and served as the Director General of the National Institute of Health of Japan. His roles in these organizations have facilitated innovative research and product development in health and diagnostics.

Collaborations: Throughout his career, Jang Hyun Han has collaborated with prominent scientists such as Michael Houghton and Qui-Lim Choo. Their combined expertise has contributed to advancements in their respective fields, particularly in virology and diagnostic methodologies.

Conclusion: Jang Hyun Han’s inventive spirit and dedication to medical science have led to significant advancements that impact healthcare positively. His 19 patents reflect his commitment to innovation, providing valuable methods and compositions that enhance our ability to treat and understand viral infections and medical diagnostics.

Profile summary based on public USPTO records.